Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.66B |
| 2 |
NVIDIA
NVDA
|
+$879M |
| 3 |
Apple
AAPL
|
+$827M |
| 4 |
Broadcom
AVGO
|
+$821M |
| 5 |
Shopify
SHOP
|
+$684M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$681M |
| 2 |
UnitedHealth
UNH
|
+$572M |
| 3 |
Meta Platforms (Facebook)
META
|
+$486M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$484M |
| 5 |
Netflix
NFLX
|
+$447M |
Sector Composition
| 1 | Technology | 26.48% |
| 2 | Financials | 12.84% |
| 3 | Industrials | 11.84% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Wayfair
W
$11.4B
| $6.94M | ﹤0.01% |
135,640
+7,917
| +6% | +$405K |
|
1977
BlackRock Debt Strategies Fund
DSU
$592M
| $6.92M | ﹤0.01% |
655,619
+4,353
| +0.7% | +$46K |
|
1978
Avidity Biosciences
RNA
$5.76B
| $6.9M | ﹤0.01% |
243,063
-45,076
| -16% | -$1.28M |
|
1979
Invesco BulletShares 2027 Municipal Bond ETF
BSMR
$270M
| $6.9M | ﹤0.01% |
293,809
+20,082
| +7% | +$471K |
|
1980
Capri Holdings
CPRI
$2.43B
| $6.88M | ﹤0.01% |
388,928
+2,373
| +0.6% | +$42K |
|
1981
Nuveen Variable Rate Preferred & Income Fund
NPFD
$475M
| $6.86M | ﹤0.01% |
355,961
+9,874
| +3% | +$190K |
|
1982
DigitalOcean
DOCN
$3.25B
| $6.86M | ﹤0.01% |
240,164
-1,096,483
| -82% | -$31.3M |
|
|
PCG.PRX
1983
PG&E Corporation 6.000% Series A Mandatory Convertible Preferred Stock
PCG.PRX
$1.3B
| $6.85M | ﹤0.01% |
182,300
+53,000
| +41% | +$1.99M |
|
1984
United States Lime & Minerals
USLM
$3.63B
| $6.84M | ﹤0.01% |
68,565
-12,100
| -15% | -$1.21M |
|
1985
Deluxe
DLX
$881M
| $6.82M | ﹤0.01% |
428,768
-316,340
| -42% | -$5.03M |
|
1986
Azenta
AZTA
$1.36B
| $6.8M | ﹤0.01% |
220,978
-750
| -0.3% | -$23.1K |
|
1987
Hillenbrand
HI
$1.73B
| $6.78M | ﹤0.01% |
337,979
-18,751
| -5% | -$376K |
|
1988
iShares MSCI South Korea ETF
EWY
$5.52B
| $6.78M | ﹤0.01% |
94,461
+76,444
| +424% | +$5.49M |
|
1989
CONMED
CNMD
$1.64B
| $6.77M | ﹤0.01% |
129,963
+5,807
| +5% | +$302K |
|
1990
Carter's
CRI
$1.08B
| $6.74M | ﹤0.01% |
223,731
+52,103
| +30% | +$1.57M |
|
|
NAGE
1991
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $6.73M | ﹤0.01% |
467,209
+100,559
| +27% | +$1.45M |
|
1992
Eastern Bankshares
EBC
$3.46B
| $6.72M | ﹤0.01% |
440,191
-44,592
| -9% | -$681K |
|
1993
Phibro Animal Health
PAHC
$1.61B
| $6.72M | ﹤0.01% |
263,073
-124,666
| -32% | -$3.18M |
|
1994
Turning Point Brands
TPB
$1.84B
| $6.68M | ﹤0.01% |
88,189
-14,679
| -14% | -$1.11M |
|
1995
Allegiant Air
ALGT
$1.19B
| $6.67M | ﹤0.01% |
121,339
+4,602
| +4% | +$253K |
|
1996
Envista
NVST
$3.49B
| $6.66M | ﹤0.01% |
340,700
-12,389
| -4% | -$242K |
|
1997
Enovix
ENVX
$1.77B
| $6.66M | ﹤0.01% |
735,608
+105,969
| +17% | +$959K |
|
|
AVDL
1998
Avadel Pharmaceuticals
AVDL
$1.5B
| $6.63M | ﹤0.01% |
748,875
+699,201
| +1,408% | +$6.19M |
|
1999
Omnicell
OMCL
$1.46B
| $6.61M | ﹤0.01% |
224,990
+1,361
| +0.6% | +$40K |
|
|
DNB
2000
DELISTED
Dun & Bradstreet
DNB
| $6.59M | ﹤0.01% |
725,270
-42,043
| -5% | -$382K |
|